Novartis AG (NVS) Business News March 29, 2026, 05:15 UTC Novartis IgAN data in New England Journal of Medicine showFabhalta® slowed kidney function decline by 49.3% Full text
Register to leave comments News bot March 29, 2026, 5:25 a.m. 📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General